10.1056/nejmoa1407222 - Chimeric Antigen Receptor T Cells for...

This document has been corrected

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Published Online: 2014-10-16

Journal: New England Journal of Medicine•Publisher: Massachusetts Medical Society

Authors: Angela Shen•Anne Chew•Bruce L. Levine•Carl H. June•David L. Porter•David M. Barrett•David T. Teachey•Jan J. Melenhorst•Nancy J. Bunin•Noelle Frey•Pamela A. Shaw•Richard Aplenc•Shannon L. Maude•Simon F. Lacey•Stephan A. Grupp•Susan R. Rheingold•Vanessa E. Gonzalez•Yolanda D. Mahnke•Zhaohui Zheng

This document has been corrected

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

10.1056/nejmoa1407222

Published Online: 2014-10-16

Journal: New England Journal of Medicine

NOW

2016-03-10•Correction

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia; Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia; Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

10.1056/nejmx160005

Reasons: Concerns/Issues about Referencing/Attributions • Error in Text • Legal Reasons and/or Threats

* information provided by RetractionWatch

2016-03-10•Correction

10.1056/nejmx160005

Reasons: Concerns/Issues about Referencing/Attributions • Error in Text • Legal Reasons and/or Threats

* information provided by RetractionWatch

2014-10-16•Published

2016-03-10•Correction

10.1056/nejmx160005

Reasons: Concerns/Issues about Referencing/Attributions • Error in Text • Legal Reasons and/or Threats

* information provided by RetractionWatch

This document has been corrected

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

10.1056/nejmoa1407222

Published Online: 2014-10-16

Journal: New England Journal of Medicine•Publisher: Massachusetts Medical Society